- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07719517
Morning Activation to Improve Mood After Stroke
This pilot randomized controlled trial will evaluate the feasibility and preliminary effects of a six-week behavioral intervention designed to improve mood and daily functioning in adults who have experienced a stroke and report depressive symptoms and difficulty becoming engaged in activities after waking.
Participants will be randomly assigned to either the behavioral intervention or a health education program. Assessments will be completed before and immediately after the six-week program and will include questionnaires and seven-day monitoring of sleep, activity, and mood. The study will also examine feasibility indices such as participant retention, intervention attendance, acceptability, and preliminary changes in mood.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Stephen Lau
- Telefoonnummer: +852 2766 4283
- E-mail: chun-lun-stephen.lau@polyu.edu.hk
Studie Locaties
-
-
-
Hong Kong, Hongkong
- Werving
- The Hong Kong Polytechnic University
-
Contact:
- Stephen Lau
- Telefoonnummer: +852 2766 4283
- E-mail: chun-lun-stephen.lau@polyu.edu.hk
-
Hoofdonderzoeker:
- Stephen Lau, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Age 18 years or older.
- History of stroke at least 6 months before enrollment.
- Patient Health Questionnaire-9 score of 10 or higher.
- Difficulty getting started or engaging in activities in the morning.
- Able to provide informed consent.
Exclusion Criteria:
- Conditions that would interfere with study participation.
- Neurological condition other than stroke.
- Currently receiving psychological therapy for depression.
- Significant cognitive impairment or dementia.
- Current or past diagnosis of psychosis, bipolar disorder, or mania.
- Hospitalization that would interfere with study participation.
- Acute or significant suicidal ideation
- Alcohol or substance use problems within the past month.
- Use of antidepressant or anti-anxiety medication unless the dosage has been stable for at least 4 weeks and no changes are planned during the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Morning Activation Program
Participants will receive a six-week individualized behavioral program delivered in weekly sessions of approximately 60 minutes.
The program is designed to support engagement in daily activities after waking, establish consistent daily routines, and improve mood and functioning after stroke.
|
A six-week individualized behavioral program delivered in weekly sessions of approximately 60 minutes.
The program is designed to support engagement in daily activities after waking, establish consistent daily routines, and improve mood and functioning after stroke.
Sessions will be tailored to participants' needs and abilities.
|
|
Actieve vergelijker: Health Education Program
Participants will receive a six-week health education program delivered in weekly sessions of approximately 60 minutes.
The program will provide general information relevant to health and recovery after stroke and will be matched to the experimental program in session frequency and duration.
It will not include the individualized behavioral strategies provided in the experimental arm.
|
A six-week health education program delivered in weekly sessions of approximately 60 minutes.
The program will provide general information relevant to health and recovery after stroke and will be matched to the experimental program in session frequency and duration.
It will not include the individualized behavioral strategies provided in the experimental arm.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Recruitment Rate
Tijdsspanne: From the start of recruitment until enrollment of the final participant.
|
Number of participants enrolled divided by the number of months of active recruitment.
|
From the start of recruitment until enrollment of the final participant.
|
|
Retention Rate
Tijdsspanne: Immediately after completion of the 6-week intervention
|
Number of randomized participants who complete the immediate post-intervention assessment divided by the total number randomized, expressed as a percentage.
|
Immediately after completion of the 6-week intervention
|
|
Intervention Attendance
Tijdsspanne: Throughout the 6-week intervention period
|
Number and percentage of scheduled intervention or health education sessions attended by each participant during the 6-week program.
|
Throughout the 6-week intervention period
|
|
Intervention Acceptability
Tijdsspanne: Immediately after completion of the 6-week intervention
|
Acceptability of the assigned program assessed using the 4-item Acceptability of Intervention Measure.
Each item is rated from 1 to 5, producing a total score ranging from 4 to 20.
Higher scores indicate greater intervention acceptability.
|
Immediately after completion of the 6-week intervention
|
|
Participants Experiencing Adverse Events
Tijdsspanne: From enrollment through completion of the immediate post-intervention assessment.
|
Number of adverse events considered related or possibly related to study participation.
|
From enrollment through completion of the immediate post-intervention assessment.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Depressive Symptoms
Tijdsspanne: Baseline and immediately after completion of the 6-week intervention
|
Depressive symptom severity assessed using the 9-item Patient Health Questionnaire-9.
Total scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.
|
Baseline and immediately after completion of the 6-week intervention
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- HSEARS20260321001
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .